FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, specifically oncology. Degarelix in an initial dose of 160 to 320 mg and then in a maintaining dose of 60 to 160 mg is administered into the individual once every 20-36 days for treating prostate cancer in the above individual.
EFFECT: given treatment provides a lower rate and/or probability of a side effect different from a side effect related to an injection point with the above side effect specified in a cardiovascular and/or vascular side effect, a musculoskeletal disturbance and/or a connective tissue disease, as well as urinary or renal disorders.
15 cl, 23 tbl, 6 dwg, 1 ex
| Title |
Year |
Author |
Number |
| DEGARELIX THERAPY OF METASTATIC STAGE OF PROSTATE CANCER |
2009 |
|
RU2504394C2 |
| NEW AUXILIARY THERAPY FOR USE IN THE TREATMENT OF PROSTATE CANCER |
2018 |
|
RU2758386C2 |
| COMPOSITION FOR TREATING PROSTATE CANCER |
2010 |
- Olesen Tine Kold
- Cantor Per
- Erichsen Lars
|
RU2536245C2 |
| OESTROGEN RECEPTOR LIGANDS AND METHODS OF USING THEM |
2010 |
- Dalton Dzhejms T.
- Stejner Mitchell S.
|
RU2543339C2 |
| RESIN COMPOSITION FOR LEUPROLIDE DELIVERY OF IMPROVED EFFECTIVENESS |
2001 |
- Dann Richard L.
- Gehrrett Dzhon S.
- Ravivarapu Kharish
- Chandrashekar Bkhagia L.
|
RU2271826C2 |
| PALMITIC ACID CONJUGATED PROLONGED GNRH DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
2018 |
|
RU2746566C2 |
| COMPOSITIONS AND METHODS FOR LONG-TERM RELEASE OF ANTAGONISTS OF GONADOTROPIN-RELEASING HORMONE (GnRH) |
2018 |
- Ravi, Kacker
- Mitchell S., Steiner
|
RU2789057C2 |
| DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES |
2016 |
|
RU2743206C2 |
| GnRH DERIVATIVES OF PROLONGED ACTION, CONJUGATED WITH FATTY ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
2019 |
|
RU2785717C2 |
| SELECTIVE ANDROGEN RECEPTOR DESTROYING AGENTS (SARD) AND METHODS OF USING THEREOF |
2016 |
- Narayanan, Ramesh
- Miller, Duane D.
- Ponnusamy, Thamarai
- Hwang, Dong-Jin
- Duke, Charles B.
- Coss, Christopher C.
- Jones, Amanda
- Dalton, James T.
|
RU2724103C2 |
